Cyclophosphamide
Relapsed Adult AML
Masonic Cancer Center, University of MinnesotaSmall moleculePhase 1/2Active
CCC
52/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 40/ 100
- Competitive Position
- 89/ 100
Competitive context
13 Active assets in the Relapsed Adult AML cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Azacitidine Institute of Hematology & Blood Diseases Hospital, China | Phase 2 | B |
Venetoclax Medical College of Wisconsin | Phase 2 | B |
Cytosin-Arabinosid Medical College of Wisconsin | Phase 2 | B |
FILGRASTIM Medical College of Wisconsin | Phase 2 | B |
Plerixafor The First Hospital of Jilin University | Phase 2 | CCC |
View all 19 →
Same molecule, other indications
Cyclophosphamide is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →